TGFB1 and neoplasm: As shown in Figure 5C, TGF-β significantly increased the motility of tumor cells: the cells, treated by this EMT stimulator, were characterized by 4.3- and 1.4-fold higher cell index in comparison with control cells at 24 h and 48 h, respectively.